<p>Overall lifetime cancer prevalence and specific subtypes of cancer prevalence in patients with MS (n = 1107) and controls (n = 1568).</p
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
Background Studies of cancer prevalence have produced conflicting results concerning the relative ri...
<div><p>Background</p><p>Studies of cancer prevalence have produced conflicting results concerning t...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
<p>PP: Primary Progressive; RR: Recurring Remitting; SP: Secondary Progressive; SEM: Standard error ...
Cancer occurrence in patients with multiple sclerosis (MS) has been little studied, but associations...
Background: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controve...
Findings regarding cancer risk in people with multiple sclerosis have been inconsistent and few stud...
Background: Multiple sclerosis (MS), a central nervous system (CNS) autoimmune disorder, affects 2.3...
Background: Studies of cancer incidence and prevalence in multiple sclerosis (MS) have produced conf...
Background Whether disease-modifying therapies (DMTs) influence cancer in multiple sclerosis (MS) i...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
Background Studies of cancer prevalence have produced conflicting results concerning the relative ri...
<div><p>Background</p><p>Studies of cancer prevalence have produced conflicting results concerning t...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
<p>PP: Primary Progressive; RR: Recurring Remitting; SP: Secondary Progressive; SEM: Standard error ...
Cancer occurrence in patients with multiple sclerosis (MS) has been little studied, but associations...
Background: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controve...
Findings regarding cancer risk in people with multiple sclerosis have been inconsistent and few stud...
Background: Multiple sclerosis (MS), a central nervous system (CNS) autoimmune disorder, affects 2.3...
Background: Studies of cancer incidence and prevalence in multiple sclerosis (MS) have produced conf...
Background Whether disease-modifying therapies (DMTs) influence cancer in multiple sclerosis (MS) i...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...